3B FUTURE Health Fund
Monaco3bfuturehealth.com
Overview
3B Future Health Fund is an early-stage venture capital fund managed by 3B Future Health Ventures. The fund supports US and European-based private early-stage, innovative companies in areas of high unmet patient needs, mainly oncology and rare disease therapeutics. They focus on start-up companies based in Europe, the US, and Israel.
Portfolio Companies
14
Website
3bfuturehealth.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kainova Therapeutics | Feb 2026 | Series B | Co-investor |
| Fore Biotherapeutics | May 2025 | Series D Extension | Co-investor |
| Epsilogen | Sep 2024 | Series B Extension | Co-investor |
| iOnctura | Jun 2024 | Series B | Co-investor |
| NeoPhore | May 2024 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
